WAM
UTHR icon

Wolverine Asset Management’s United Therapeutics UTHR Stock Holding History

Wolverine Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-16
Closed -$1K – 1789
2020
Q2 		$1K Buy
+16
New +$1.8K ﹤0.01% 1500
2016
Q1 		– Sell
-4,240
Closed -$537K – 1640
2015
Q4 		$664K Buy
+4,240
New +$617K 0.01% 583

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Wolverine Asset Management's UTHR Position: Q3 2020 in Review

Wolverine Asset Management sold out of United Therapeutics (UTHR) in Q3 2020, closing a stake of 16 shares — an estimated $1K sold.

Wolverine Asset Management first reported a position in UTHR in Q4 2015 and held it in 2 quarters. The position peaked at $664K in Q4 2015. 333 funds tracked by Wall St. Rank hold UTHR as of Q3 2020.

  • Wolverine Asset Management reported no remaining United Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Wolverine Asset Management sold 16 United Therapeutics shares in Q3 2020, an estimated $1K.
  • Wolverine Asset Management first reported a position in United Therapeutics in Q4 2015 and held it in 2 quarters.
  • Wolverine Asset Management's United Therapeutics position peaked at $664K in Q4 2015.
  • 333 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2020.

Based on Wolverine Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.